These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3470941)
1. Agranulocytosis secondary to extended-release procainamide: a case report and review of the literature. A case of agranulocytosis caused by procainamide in a patient who had undergone open-heart surgery. Malters PB; Salem AG S D J Med; 1987 Feb; 40(2):7-10. PubMed ID: 3470941 [No Abstract] [Full Text] [Related]
2. [Agranulocytosis caused by procainamide (Pronestyl)]. Hensen A Ned Tijdschr Geneeskd; 1974 Apr; 118(17):624-5. PubMed ID: 4133296 [No Abstract] [Full Text] [Related]
3. Agranulocytosis due to new sustained-release procainamide. Berger BE; Hauser DJ Am Heart J; 1983 Jun; 105(6):1035-6. PubMed ID: 6858823 [No Abstract] [Full Text] [Related]
5. Procainamide-induced agranulocytosis: report of two cases and review. Nagesh KG; Poulose KP; Tseng TH; Schadchehr A J Kans Med Soc; 1980 Jan; 81(1):18-24. PubMed ID: 6153211 [No Abstract] [Full Text] [Related]
6. Agranulocytosis associated with procainamide therapy--report of a case. Prince RA; Brown BT; Jacknowitz AI Am J Hosp Pharm; 1977 Dec; 34(12):1362-5. PubMed ID: 596390 [TBL] [Abstract][Full Text] [Related]
7. Procainamide-induced agranulocytosis. Reidy TJ; Upshaw JD South Med J; 1984 Dec; 77(12):1582-4. PubMed ID: 6505768 [TBL] [Abstract][Full Text] [Related]
9. Severe neutropenia associated with sustained-release procainamide. Ellrodt AG; Murata GH; Riedinger MS; Stewart ME; Mochizuki C; Gray R Ann Intern Med; 1984 Feb; 100(2):197-201. PubMed ID: 6691661 [TBL] [Abstract][Full Text] [Related]
10. Agranulocytosis, thrombocytopenia, and procainamide. Christensen DJ; Palma LF; Phelps K Ann Intern Med; 1984 Jun; 100(6):918. PubMed ID: 6721310 [No Abstract] [Full Text] [Related]
11. Severe neutropenia associated with procainamide: comparison of sustained release and conventional preparations. Meyers DG; Gonzalez ER; Peters LL; Davis RB; Feagler JR; Egan JD; Nair CK Am Heart J; 1985 Jun; 109(6):1393-5. PubMed ID: 4003250 [No Abstract] [Full Text] [Related]
12. Severe neutropenia due to sustained-release procainamide. Hoyt RE South Med J; 1987 Sep; 80(9):1196-7. PubMed ID: 3629327 [TBL] [Abstract][Full Text] [Related]
13. Sustained-release procainamide and neutropenia. Anderson S; Wenger NK Ann Intern Med; 1984 Sep; 101(3):404. PubMed ID: 6465719 [No Abstract] [Full Text] [Related]
14. Reversible severe anaemia and granulocytopenia caused by procainamide. A case report. van Beek RJ; Bieger R; den Ottolander GJ Scand J Haematol; 1978 Aug; 21(2):150-2. PubMed ID: 694426 [TBL] [Abstract][Full Text] [Related]
15. Neutropenia associated with procainamide. Kimmel DP; Antignano LV; Barold SS; Boros L; Olson JP N Y State J Med; 1985 May; 85(5):197. PubMed ID: 3859759 [No Abstract] [Full Text] [Related]
16. Procainamide and neutropenia. Ann Intern Med; 1984 May; 100(5):766-7. PubMed ID: 6712043 [No Abstract] [Full Text] [Related]
17. Desensitization to procainamide. Ream CR; Barrera R J Med Soc N J; 1970 Mar; 67(3):107-10. PubMed ID: 5264623 [No Abstract] [Full Text] [Related]
18. Agranulocytosis in a 12-year-old girl treated with procainamide. Gunay U; Honig GR Clin Pediatr (Phila); 1974 Sep; 13(9):728-30. PubMed ID: 4411903 [No Abstract] [Full Text] [Related]